about
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development...
Read More
18.32
-0.08
(-0.43%)
821.8K
XNAS Volume
XNAS 20 Oct, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Zymeworks BC Inc is on 31 Oct 2025 for the purpose of Zymeworks Inc Third Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Zymeworks BC Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..